AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 261: H1927-H1936, 1991;
0363-6135/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gopalakrishnan, V.
Right arrow Articles by McNeill, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gopalakrishnan, V.
Right arrow Articles by McNeill, J. R.

AJP - Heart and Circulatory Physiology, Vol 261, Issue 6 1927-H1936, Copyright © 1991 by American Physiological Society


ARTICLES

Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells

V. Gopalakrishnan, Y. J. Xu, P. V. Sulakhe, C. R. Triggle and J. R. McNeill
Department of Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.

We report saturable, high-affinity, specific, reversible binding sites for both [3H]arginine vasopressin ([3H]AVP) and d(CH2)5Tyr(Me)-[3H]AVP, a V1-selective antagonist, in cultured smooth muscle cells obtained from rat aorta (RA) and rat mesenteric artery (RMA). Specific binding of [3H]AVP had the following characteristics in adherent monolayers of RA and RMA smooth muscle cells: dissociation constant (KD) = 1.42 and 1.23 nM and maximal binding capacity (Bmax) = 9,500 and 29,910 sites/cell, respectively. Lower KD and higher Bmax values were detected for 3H-labeled V1 antagonist binding to both types of cells. Complete dissociation of [3H]-AVP binding to RA cells occurred in a biphasic manner with two rate constants of dissociation, suggesting high- and low-affinity states of the binding site for the agonist interaction. Partial dissociation of the antagonist-specific binding occurred, and it was monophasic, suggesting interaction of the 3H-labeled V1 antagonist radioligand to the high-affinity binding state. Inhibition constant (Ki) values determined by competitive inhibition of [3H]AVP binding to RA cells by a series of AVP-related peptide analogues and antagonists were consistent with the saturation data. AVP in a concentration-dependent manner induced the accumulation of inositol phosphates [mean effective concentration (EC50) 1 nM] in the adherent RA cells. The free cytosolic Ca2+ level in the dispersed RA smooth muscle cells was increased by AVP (EC50 8.1 nM). Pretreatment with the V1 antagonist abolished these AVP-evoked responses. The data support the conclusion that the agonist binding occurs at a homogeneous population of V1-subtype receptors in the high-affinity (KD = approximately 1 nM) state and that these receptors are functionally coupled to phospholipase C.


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. GREEN, S. ASSADY, F. NAKHOUL, T. BICK, P. JAKOBI, and Z. ABASSI
Differential Effects of Sera from Normotensive and Hypertensive Pregnant Women on Ca2+ Metabolism in Normal Vasular Smooth Muscle Cells
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1188 - 1198.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Burnatowska-Hledin, I. B. Lazdins, L. Listenberger, P. Zhao, A. Sharangpani, V. Folta, and B. Card
VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule
Am J Physiol Renal Physiol, February 1, 1999; 276(2): F199 - F209.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Levesque, N. M. Dean, H. Sasmor, and S. T. Crooke
Antisense Oligonucleotides Targeting Human Protein Kinase C-alpha Inhibit Phorbol Ester-Induced Reduction of Bradykinin-Evoked Calcium Mobilization in A549 Cells
Mol. Pharmacol., February 1, 1997; 51(2): 209 - 216.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online